In vitro activity of meropenem combined with vaborbactam against KPC-producing Enterobacteriaceae in China
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dky251
Abstract: Background Vaborbactam is a novel inhibitor of serine β-lactamases, including KPCs, which predominate in China. It is being developed in combination with meropenem. Methods Using the broth microdilution method, the in vitro activity of meropenem/vaborbactam… read more here.
Keywords: vaborbactam; producing enterobacteriaceae; meropenem; activity ... See more keywords